Fig. 2From: High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortalitySurvival curves at 30 days using serum levels of caspase-cleaved cytokeratin (CCCK)-18 higher or lower than 298 u/LBack to article page